Head of Global Solutions Architect
PingCAPFull Time
Expert & Leadership (9+ years)
Candidates should possess a Bachelor’s degree in a scientific discipline, such as Biology, Chemistry, or Pharmacology, and ideally hold a Master’s or Doctoral degree. They should have at least 8 years of experience in scientific publications, with a strong understanding of the pharmaceutical industry and regulatory guidelines. Experience managing teams and collaborating with cross-functional teams is also required.
The Director, Global Scientific Publications will oversee the management and delivery of scientific publications in alignment with brand publication plans, collaborating with internal and external stakeholders to review and provide scientific consultation regarding publication-related material. They will strategize and identify publication opportunities, coordinate publication activities with vendors and internal teams, monitor publication requirements for congresses and journals, define operational milestones, and ensure adherence to regulatory requirements and SOPs. The role also involves acting as a liaison at meetings, submitting abstracts and clinical papers, attending scientific congresses, applying scientific acumen, and documenting publication processes through PubSTRAT.
Develops therapies for CNS disorders
Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.